National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT)

 

As per the National Guidelines on Stem Cell Research -2013, at present, there are no approved indications for stem cell therapy other than the hematopoietic stem cell transplantation (HSCT) for haematological disorders. Accordingly all stem cell therapy other than the above shall be treated as investigational and conducted only in the form of a clinical trial after obtaining necessary regulatory approvals. Use of stem cells for any other purpose outside the domain of clinical trial will be considered unethical and hence is not permissible

Circular

Download Format

 
Indian institutions  working in the area of Stem Cell Research and Therapy  should  send the information pertaining to their Institutional Committee for Stem Cell Research and Therapy (IC-SCRT)  as per format to the following address :
 
Member Secretary,
National Apex Committee for Stem Cell Research and Therapy
ICMR Headquarters Office,
Ramlingaswamy Bhawan,
New Delhi-110029.

 

Home Page